Log in to post a reply
Jan 23, 2010 08:49AM
That is great that you are responding so quickly to neodjuvant chemo! It is not unusual for triple negs, such as yourself, to get a complete pathological response so they don't see any tumor when it's time for surgery.
I'm sure they will continue will all the chemo txs. As Laurie09 mentions, the chemo continues to affect any rougue cells in the body and anything that may be in the lymph nodes. I expect that they will perform the sentinel biopsy at the time of surgery to determine if any lymph are affected and if they are, remove them at that time.
It may also be an option to do a lumpectomy at surgery time after successful neoadjuvant. But it depends on the location of the tumor in the breast. I'm not sure if it's an option if the tumor is close to the chest wall. In my case, it was never an option because I have multiple tumors and all quandrants of the breast are affected. My neoadjuvant chemo is to kill any rougue cancer, reduce the lymph nodes (they were easy felt and showed on US, MRI and PET) and reduce the tumors so they can get clear margins when it's time for my mastectomy.
I hope your tx continues on this positive path!
Christy - BRCA2+; mets to bones and liver, Taxol/Sutent -> AC, BMX - no recon, Rads, Carboplatin, BSO, Veliparib trial (8/30/13-3/13/14)
7/21/2009, ILC, 5cm, Stage IIIC, Grade 3, 14/17 nodes, ER+/PR+, HER2-
9/9/2012, ILC, Stage IV, Grade 3, ER+/PR-, HER2-
08/16/2013 Faslodex (chemical name: fulvestrant, class: estrogen receptor downregulator (ERD))
09/01/2010 Aromasin (chemical name: exemestane, class: aromatase inhibitor)
09/09/2012 Femara (chemical name: letrozole, class: aromatase inhibitor)
03/20/2014 Carboplatin (brand name: Paraplatin)
03/29/2013 Xeloda (chemical name: capecitabine)